Evidence Hub

Track evidence momentum and emerging diabetes research intelligence. Monitor relationship strength changes, identify accelerating evidence, and explore validated research insights.

Early access β€” Evidence base actively growing

Last updated: 5/31/2026

πŸ“š
62
Research Documents
πŸ”—
342
Evidence Pairs
πŸ’Š
121
Interventions
🎯
153
Outcomes
πŸ“‚
7
Intervention Categories (L1)
πŸ“Š
7
Outcome Categories (L1)
➑️

Featured Evidence Shift

Dapagliflozin β†’ HbA1c

Strongest evidence in the database

This relationship has 3 studies with limited evidence, representing the most robust finding in our evidence base.

πŸ“Œ Temporal tracking activates with monthly snapshots

Evidence Intelligence Snapshot

View all insights β†’

Strongest Evidence Relationship

Dapagliflozin β†’ HbA1c

55 Evidence Score
Explore evidence β†’

Research Documents Analyzed

Peer-reviewed studies in evidence base

62 peer-reviewed studies analyzed

Strong Evidence Areas

Relationships with strong or very strong ratings

0 – No strong evidence areas yet
No evidence available

Most Consistent Finding

Highest consistency score observed

100% consistency

Evidence Pairs Analyzed

Intervention-outcome combinations

342 evidence relationships analyzed

Most Studied Relationship

Highest research volume observed

3 studies on single relationship
πŸ“Š

Temporal Intelligence Coming Soon

Evidence trends, state changes, and momentum history will activate once monthly snapshots accumulate. Requires at least two monthly evidence snapshots. Temporal intelligence will activate once historical data accumulates.

πŸ›‘οΈ

Most Validated Relationships

Intervention-outcome relationships with the strongest evidence validation and replication

RelationshipEvidence StrengthStudiesConsistencyActions
Dapagliflozin β†’ HbA1c
limited3consistent
Metformin β†’ Fasting Plasma Glucose
limited2consistent
Semaglutide β†’ Body weight
limited2consistent
Semaglutide β†’ HbA1c
limited2consistent
Dapagliflozin β†’ Body weight
limited1(Single study)unclear
Dapagliflozin β†’ Renal and urinary disorders incidence
limited1(Single study)unclear

Scroll horizontally to see all columns

Evidence Collections

Curated collections of evidence organized by strength, topic, and clinical relevance

πŸ“‹

Browse by Category

All major intervention and outcome categories in one place

CategoryTypeInterventions / OutcomesEvidence PairsStrongest EvidenceView
Behavioral & Lifestyleintervention4478LimitedView category β†’
Physical Activityintervention1626LimitedView category β†’
Supplementsintervention3148LimitedView category β†’
Medicationsintervention42122LimitedView category β†’
Diet and Nutritionintervention1634LimitedView category β†’
Devices & Technologyintervention2033LimitedView category β†’
Proceduresintervention11LimitedView category β†’
Metabolic Healthoutcome2471LimitedView category β†’
Weight & Anthropometricsoutcome2643LimitedView category β†’
Glycemic Controloutcome53135LimitedView category β†’
Clinical Outcomesoutcome1426LimitedView category β†’
Adherence & Engagementoutcome1114LimitedView category β†’
Patient Reportedoutcome1021LimitedView category β†’
Safetyoutcome2332LimitedView category β†’